\n
\u00a0<\/strong>Like many countries in the world, Mali was faced with the COVID-19 pandemic. In Mali, 30,752 people were affected by COVID-19 between 2020 and 2022, of whom 29,828 were cured and 731 died (MSDS, 2022). According to the International Diabetes Federation (IDF Diabetes), Mali was more affected by type 2 diabetes, with an estimated 1.8% (Atlas, 2021). Diabetes and hypertension are the most common co-morbidities among COVID-19 deaths, at 20.45% and 17.42% respectively (Kon\u00e9 B, 2021). The aim of this study was to analyze the clinical and biological aspects of COVID-19 and diabetes in Mali from 2020 to 2023.<\/p>\n The present research constitutes a comparative cross-sectional analytical study of the clinical and biological aspects of COVID-19 and diabetes in Mali 2020 to 2023. It was conducted from June 2 to December 15, 2023, on fifty (50) patients selected from an exhaustive literature review of 105 patient medical records at the Mali Hospital and in the referral health centers (Csr\u00e9f) of Commune I and Commune VI. Data collection was carried out in patients’ homes, in the form of individual interviews. Data were then analyzed and processed using SPSS version 21 software and Office 2016 Excel and Word. However, the study showed that before the pandemic, 34% of patients were obese, whereas no obese patients were recorded during or after the pandemic. In addition, before the pandemic, 54% of patients had unbalanced diabetes.\u00a0 In addition, during the pandemic, nine patients (18%) desaturated, whereas none desaturated before or after the COVID-19 infection. This oxygen desaturation was more remarkable in men (59%) than in women (41%) in the 65-74 age group. Cases of diabetic ketoacidosis were recorded in only 6% of patients during the pandemic. Arterial hypertension is the only macro-angiopathic complication found in patients, with an increase in frequency during the pandemic. Respiratory distress was observed in nine (25%) patients during COVID-19 infection, compared with five (29%) after the pandemic. On the curative side, fifty-seven percent of caregivers used insulin to treat hyperglycemia during diabetes, and 14% treated COVID-19 according to the Mali protocol. Finally, the clinical and biological aspect of COVID-19 and diabetes in Mali 2020 to 2023 proved that the pandemic is a risk factor associated with diabetes in the same way as diabetes to alter the health of patients.<\/p>\n Keywords: <\/strong>Impact, Covid-19, diabetes care, Bamako, Mali<\/p>\n<\/header>\n Titre<\/strong> : Aspects clinique et biologique de la covid-19 et du diab\u00e8te au Mali de 2020 \u00e0 2023. Abstract\u00a0 \u00c0 l\u2019instar de plusieurs pays au monde, le Mali \u00e9tait confront\u00e9 \u00e0 la pand\u00e9mie de COVID-19. Ainsi, au Mali, 30.752 personnes sont atteintes de COVID-19 entre 2020 et 2022, parmi ces patients, 29.828 patients sont gu\u00e9ris et 731 patients sont d\u00e9c\u00e9d\u00e9s (MSDS, 2022). Selon la f\u00e9d\u00e9ration internationale du diab\u00e8te (IDF Diabetes), le Mali est…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_kad_post_transparent":"default","_kad_post_title":"default","_kad_post_layout":"default","_kad_post_sidebar_id":"","_kad_post_content_style":"default","_kad_post_vertical_padding":"default","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[174,38,177,13,220,224,36,12],"tags":[109],"class_list":["post-3373","post","type-post","status-publish","format-standard","hentry","category-article","category-health-and-biomedical-sciences","category-jsse","category-psychology","category-rjsse-volume-36","category-rufso-rjsse-volume-36-issue-2","category-management-sciences","category-social-sciences","tag-moussa-issa-lende"],"_links":{"self":[{"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/posts\/3373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/comments?post=3373"}],"version-history":[{"count":8,"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/posts\/3373\/revisions"}],"predecessor-version":[{"id":3423,"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/posts\/3373\/revisions\/3423"}],"wp:attachment":[{"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/media?parent=3373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/categories?post=3373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rufso.ac.cd\/journal\/rjsse\/wp-json\/wp\/v2\/tags?post=3373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>Summary<\/strong><\/p>\n
\n
\nAuteur(s)<\/strong> : Moussa Issa Lende<\/a><\/em>
\nAffiliation:<\/strong> Laboratoire de Sant\u00e9 et Biom\u00e9dicale Centre Interuniversitaire de recherche pluridisciplinaire(CIREP)_www.cirep.ac.cd
\nPubli\u00e9 dans\u00a0<\/strong>\u00a0\u00a0Journal des sciences sociales et de l\u2019ing\u00e9nierie<\/a>\u00a0,\u00a0\u00a0Volume 36<\/a>\u00a0\u00a0,\u00a0\u00a0<\/em>num\u00e9ro 2<\/a>
\ndoi<\/strong>\u00a0:\u00a010.55272\/rufso.rjsse<\/a>
\n<\/em><\/p>\nT\u00e9l\u00e9charger en PDF<\/a><\/strong><\/h3>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"